ATIF  IQBAL  to  Retrospective Studies
                            
                            
                                This is a "connection" page, showing publications  ATIF  IQBAL  has written about  Retrospective Studies.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.333
         
        
        
     
 
    
        
        - 
            OPTIMIZING POSTOPERATIVE OUTCOMES: ASSESSING THE EFFECT OF ENHANCED RECOVERY AFTER SURGERY (ERAS) PROTOCOLS IN GENERAL SURGICAL PATIENTS. J Ayub Med Coll Abbottabad. 2024 Apr-Jun; 36(2):359-363.
            
            
                Score: 0.061
             
- 
            Validation of a pelvic surgery difficulty risk model to predict difficult pelvic dissection and poor outcomes. Surgery. 2023 05; 173(5):1199-1204.
            
            
                Score: 0.056
             
- 
            The Impact of a Narcotic-Sparing Enhanced Recovery Protocol on Postoperative Narcotic Use Following Colectomy. Dis Colon Rectum. 2023 08 01; 66(8):1102-1109.
            
            
                Score: 0.053
             
- 
            Effects of Preoperative Use of Biologic Agents on Operative Outcomes in Crohn's Disease Patients. Am Surg. 2018 Sep 01; 84(9):1526-1530.
            
            
                Score: 0.041
             
- 
            Rectal cancer patients younger than 50 years lack a survival benefit from NCCN guideline-directed treatment for stage II and III disease. Cancer. 2018 09 01; 124(17):3510-3519.
            
            
                Score: 0.041
             
- 
            Readmission After Elective Ileostomy in Colorectal Surgery Is Predictable. JSLS. 2018 Jul-Sep; 22(3).
            
            
                Score: 0.041
             
- 
            Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy. J Natl Cancer Inst. 2018 05 01; 110(5):460-466.
            
            
                Score: 0.040